medigraphic.com
ISSN 1659-1046 (Print)
Odovtos - International Journal of Dental Sciences

2023, Number 2

<< Back Next >>

Odovtos-Int J Dent Sc 2023; 25 (2)

Assessment of Electromyography in Evaluating Masseter Muscle Activity in Oral Submucous Fibrosis with Different Treatment Modalities: a Systematic Review

Poornachitra P, Uma MTN

Language: English
References: 35
Page: 10-19
PDF size: 193.31 Kb.


ABSTRACT

Electromyography (EMG) is used for the measurement of muscle activity to characterize the nature of muscle contraction in Oral submucous fibrosis (OSMF). Aim: To assess the efficacy of EMG in evaluating masseter muscle activity in the management of OSMF. This review identified 73 records from standard databases which were rigorously screened with eligibility criteria and 3 clinical studies were identified based on our inclusion criteria. The quality of included studies was assessed by the PEDro scale and data was synthesized with detailed characterization. The Risk of Bias assessment among studies was done using the ROBINS-I tool and a meta-analysis could not be done due to high clinical heterogeneity. Our result recommends that EMG be used as an objective prognosis assessment tool by quantifying the management of OSMF irrespective of the intervention applied. However, it is not to be considered the gold standard as of now with limited data pooled and needs to be further assessed with clinical trials. EMG can be advocated as a reliable adjunct assessment for measuring the interventional outcome of OSMF irrespective of treatment modalities.


REFERENCES

  1. Cox S.C., Walker D.M. Oral submucousfibrosis. A review. Australian Dental Journal1996; 41: 294-9.

  2. Tak J., Gupta N., Bali R. Oral SubmucousFibrosis: A Review Article on Etiopathogenesis.Kathmandu University Medical Journal2015; 12: 153-6.

  3. Rao N.R., Villa A., More C.B., JayasingheR.D., Kerr A.R., Johnson N.W. Oral submucousfibrosis: a contemporary narrativereview with a proposed inter-professionalapproach for an early diagnosis and clinicalmanagement. J Otolaryngol Head Neck Surg2020; 49: 3.

  4. Bari S., Metgud R., Vyas Z., Tak A. An updateon studies on etiological factors, diseaseprogression, and malignant transformation inoral submucous fibrosis. J Cancer Res Ther2017; 13: 399-405.

  5. Pant I., Rao S.G., Kondaiah P. Role of arecanut induced JNK/ATF2/Jun axis in the activationof TGF-β pathway in precancerous OralSubmucous Fibrosis. Sci Rep 2016; 6: 34314.

  6. Cui L., Cai X., Huang J., Li H., Yao Z.Molecular mechanism of Oral SubmucousFibrosis Induced by Arecoline: A literaturereview. J Clin Diagn Res 2020; 14 (7):ZE01-ZE05.

  7. Iqbal A., Tamgadge S., Tamgadge A., PereiraT., Kumar S., Acharya S., et al. Evaluationof Ki-67 Expression in Oral SubmucousFibrosis and Its Correlation with Clinical andHistopathological Features. J Microsc Ultrastruct2020; 8: 20-4.

  8. Binnie W.H., Cawson R.A. A new ultrastructuralfinding in oral submucous fibrosis. Br JDermatol 1972; 86: 286-90.

  9. el-Labban N.G., Canniff J.P. Ultrastructuralfindings of muscle degeneration in oralsubmucous fibrosis. J Oral Pathol 1985; 14:709-17.

  10. Chawla H., Urs A-B., Augustine J., Kumar P.Characterization of muscle alteration in oralsubmucous fibrosis-seeking new evidence.Med Oral Patol Oral Cir Bucal 2015; 20:e670-7.

  11. Chakarvarty A., Panat S.R., Sangamesh N.C.,Aggarwal A., Jha P.C. Evaluation of massetermuscle hypertrophy in oral submucous fibrosispatients -an ultrasonographic study. J ClinDiagn Res 2014; 8: ZC45-7.

  12. Basmajian J.V., De Luca C.J. Muscles Alive:Their Functions Revealed by Electromyography.Williams & Wilkins; 1985.

  13. Turker H., Sze H. Surface Electromyographyin Sports and Exercise. Electrodiagnosis inNew Frontiers of Clinical Research 2013.

  14. Placzek J.D., Boyce D.A. OrthopaedicPhysical Therapy Secrets - E-Book. ElsevierHealth Sciences; 2016.

  15. Molnar C., Gair J. Concepts of biology, 1stCanadian edition 2015.

  16. Kuo I.Y., Ehrlich B.E. Signaling in musclecontraction. Cold Spring Harb Perspect Biol2015; 7: a006023.

  17. Fryer G., Bird M., Robbins B., Fossum C.,Johnson J.C. Resting ElectromyographicActivity of Deep Thoracic TransversospinalisMuscles Identified as Abnormal With Palpation.Int J Osteopath Med 2010; 110: 61-8.

  18. Moruzzi G. The electrophysiological work ofCarlo Matteucci. 1964. Brain Res Bull 1996;40: 69-91.

  19. Wan J-J., Qin Z., Wang P-Y., Sun Y., Liu X. Muscle fatigue: general understanding and treatment. Exp Mol Med 2017; 49: e384.

  20. Encyclopedia of the Neurological Sciences 2014.

  21. De Luca C.J. Physiology and mathematics of myoelectric signals. IEEE Trans Biomed Eng 1979; 26: 313-25.

  22. Kutz M. Biomedical Engineering and Design Handbook, Volume 2: Volume 2: Biomedical Engineering Applications. McGraw Hill Professional; 2009.

  23. PROSPERO n.d. https://www.crd.york.ac.uk/prospero/ (accessed July 23, 2022).

  24. Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 2021;10: 89.

  25. Clinimetrics: Physiotherapy Evidence Database (PEDro) Scale. J Physiother 2020; 66: 59.

  26. Sandercock P. The authors say: “The data are not so robust because of heterogeneity” - so, how should I deal with this systematic review? Meta-analysis and the clinician. Cerebrovasc Dis 2011;31: 615-20.

  27. Ioannidis J.P.A., Patsopoulos N.A., Rothstein H.R. Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 2008; 336: 1413-5.

  28. Sterne J.A., Hernán M.A., Reeves B.C., Savović J., Berkman N.D., Viswanathan M., et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919.

  29. Kant P., Bhowate R.R., Sharda N. Assessment of cross-sectional thickness and activity of masseter, anterior temporalis and orbicularis oris muscles in oral submucous fibrosis patients and healthy controls: an ultrasonography and electromyography study. Dentomaxillofac Radiol 2014; 43: 20130016.

  30. Sinha G., Sharma M.L., Ram C.S. An electromyographic evaluation of orbicularis oris and masseter muscle in pretreatment and posttreatment patients of oral submucous fibrosis: A prospective study. J Indian Acad Oral Med Radiol 2018; 30: 210.

  31. Shandilya S., Mohanty S., Sharma P., Chaudhary Z., Kohli S., Kumar R.D. Effect of botulinum toxin-A on pain and mouth opening following surgical intervention in oral submucous fibrosis - A controlled clinical trial. J Craniomaxillofac Surg 2021; 49: 675-81.

  32. Kebede B., Megersa S. Idiopathic masseter muscle hypertrophy. Ethiop J Health Sci 2011; 21: 209-12.

  33. Jian C., Wei M., Luo J., Lin J., Zeng W., Huang W., et al. Multiparameter Electromyography Analysis of the Masticatory Muscle Activities in Patients with Brainstem Stroke at Different Head Positions. Front Neurol 2017; 0. https://doi.org/10.3389/fneur.2017.00221

  34. Szyszka-Sommerfeld L., Machoy M., Lipski M., Woźniak K. The Diagnostic Value of Electromyography in Identifying Patients With Pain-Related Temporomandibular Disorders. Front Neurol 2019; 10: 180.

  35. Szyszka-Sommerfeld L., Machoy M., Lipski M., Woźniak K. Electromyography as a Means of Assessing Masticatory Muscle Activity in Patients with Pain-Related Temporomandibular Disorders. Pain Res Manag 2020; 2020: 9750915




2020     |     www.medigraphic.com